Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache

NCT00055484 is registered in ClinicalTrials.gov with Elan Pharmaceuticals as lead sponsor.

NCT NCT00055484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00055484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache
Lead sponsor
Elan Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2002
Completion date
May 31, 2003
Enrollment
204
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache